AI Analysis AI Analysis of BLRX
Powered by GPT-4o
New!
Stock Analysis PRO
Stock Analysis
Risk Assessment
Trading Strategy
PDF

BioLineRx Ltd. stock downgraded from Strong Buy Candidate to Buy Candidate after Thursday trading session
(Updated on Jul 10, 2025)

Buy candidate since Jul 09, 2025 Loss -0.81%

The BioLineRx Ltd. stock price fell by -0.81% on the last day (Thursday, 10th Jul 2025) from $4.92 to $4.88. During the last trading day the stock fluctuated 3.59% from a day low at $4.74 to a day high of $4.91. The price has been going up and down for this period, and there has been a 8.81% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -13 thousand shares and in total, 56 thousand shares were bought and sold for approximately $272.36 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 52.31% during the next 3 months and, with a 90% probability hold a price between $6.71 and $10.27 at the end of this 3-month period.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock . Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)
IBKR Logo

BLRX Signals & Forecast

The BioLineRx Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $4.58 and $4.53. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 09, 2025, and so far it has fallen -17.71%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for BioLineRx Ltd. stock

BioLineRx Ltd. finds support from accumulated volume at $4.66 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.170 between high and low, or 3.59%. For the last week the stock has had daily average volatility of 8.23%.

Our recommended stop-loss: $4.67 (-4.21%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 21 days ago.)

Trading Expectations (BLRX) For The Upcoming Trading Day Of Friday 11th

For the upcoming trading day on Friday, 11th we expect BioLineRx Ltd. to open at $4.84, and during the day (based on 14 day Average True Range), to move between $4.45 and $5.31, which gives a possible trading interval of +/-$0.428 (+/-0%) up or down from last closing price. If BioLineRx Ltd. takes out the full calculated possible swing range there will be an estimated 0% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.66 (4.61%) than the resistance at $5.25 (7.58%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is BioLineRx Ltd. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for BioLineRx Ltd. stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 1.617 Buy Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 11, 2025 - $4.84 ( 0.751%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*

BLRX Performance

Trading levels for BLRX

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis Powered by GPT-4o*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 5.01 2.73%
R2 4.95 1.40%
R1 4.91 0.579%
Price 4.88
S1 4.78 -2.08%
S2 4.74 -2.90%
S3 4.67 -4.23%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.93 21.52%
R2 5.74 17.62%
R1 5.25 7.58%
Price 4.88
S1 4.66 -4.61%
S2 4.22 -13.52%
S3 4.10 -15.98%

FAQ

What is the symbol for BioLineRx Ltd. Stock and on which exchange is it traded?
The symbol for BioLineRx Ltd. is BLRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioLineRx Ltd. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for BioLineRx Ltd. stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

How to buy BioLineRx Ltd. Stock?
BioLineRx Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioLineRx Ltd. Stock.

What's the current price of BioLineRx Ltd. Stock?
As of the end of day on the Jul 10, 2025, the price of an BioLineRx Ltd. (BLRX) share was $4.88.

What is the 52-week high and low for BioLineRx Ltd. Stock?
The 52-week high for BioLineRx Ltd. Stock is $35.60 and the 52-week low is $2.30.

What is the market capitalization of BioLineRx Ltd. Stock?
As of the Jul 10, 2025, the market capitalization of BioLineRx Ltd. is 392.893M.

When is the next earnings date for BioLineRx Ltd.?
The upcoming earnings date for BioLineRx Ltd. is Aug 21, 2025.
Click to get the best stock tips daily for free!
ABOUT BIOLINERX LTD.
BioLineRx Ltd.
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat...
GOLDEN STAR
Ticker Change Signal Date
RYTM
$62.29
42.94% Jun 25
NOV
$12.25
12.33% Jun 04
G
GTM
$9.57
8.36% Jun 02
UAA
$5.84
21.23% May 09
HBM
$7.41
45.61% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE